ENSAYO PARA DETERMINACIÓN DE ANTICUERPOS HUMANOS IGG CONTRA MIELOPEROXIDASA Y PROTEINASA 3.
Mexico·Clase I·III. Agentes de diagnóstico·INOCHEM SA DE CV·Registered August 09, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- EUROLINE ANTI-MPO, -PR3 (IGG)
- Trade Name (English)
- EUROLINE ANTI-MPO, -PR3 (IGG)
- Analysis ID
- 0704R2022 SSA
- Registration Date
- August 09, 2022
- Name (Spanish)
- INOCHEM SA DE CV
- Name (English)
- INOCHEM SA DE CV
Access comprehensive regulatory information for ENSAYO PARA DETERMINACIÓN DE ANTICUERPOS HUMANOS IGG CONTRA MIELOPEROXIDASA Y PROTEINASA 3. (ENSAYO PARA DETERMINACIÓN DE ANTICUERPOS HUMANOS IGG CONTRA MIELOPEROXIDASA Y PROTEINASA 3.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0704R2022 SSA and manufactured by INOCHEM SA DE CV. The device was registered on August 09, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.